How Your Body Data Could Reshape Sectors

Watch on YouTube ↗  |  May 12, 2026 at 21:21  |  5:10  |  Morgan Stanley
Speakers
Aaron Wright — US healthcare services analyst, Morgan Stanley

Summary

Aaron Wright, Morgan Stanley's US healthcare services analyst, discusses how proactive health tracking through wearables and direct-to-consumer lab testing is creating an investable theme. He estimates that expanded prevention could save $200B-$800B in healthcare costs by 2050, and outlines implications for consumer, fitness, and imaging sectors.

  • The shift from reactive to proactive healthcare is an investable theme.
  • Direct-to-consumer lab testing market is $4B and growing rapidly.
  • Wearables are used by 41% of respondents and drive behavior change.
  • Preventative testing could avoid $200B-$800B of US healthcare spend by 2050.
  • Health tracking may reshape consumer food choices toward functional benefits.
  • Fitness sector could benefit as gyms add wellness services.
  • Imaging is an emerging area for earlier disease detection.
  • Risks include out-of-pocket costs, privacy concerns, and inconsistent use.
Up Next